Search Within
Document Type
112-60-7
Applied Filters:
Keyword:'112-60-7'
Showing 1-30 of 327 results for "112-60-7" within Technical Documents
Product Information Sheet-11204530001
substrate
and 60 mg vehicle substances.
11 112 422 001 1 bottle,
20 tablets
ABTS Buffer Contains sodium perborate, citric acid,
and disodium hydrogen phosphate.
11 112 597 001 1 bottle
Product Information Sheet - 11112597001
substrate
and 60 mg vehicle substances.
11 112 422 001 1 bottle,
20 tablets
ABTS Buffer Contains sodium perborate, citric acid,
and disodium hydrogen phosphate.
11 112 597 001 1 bottle
Product Information Sheet - ABTSRO
substrate
and 60 mg vehicle substances.
11 112 422 001 1 bottle,
20 tablets
ABTS Buffer Contains sodium perborate, citric acid,
and disodium hydrogen phosphate.
11 112 597 001 1 bottle
Product Information sheet-SRP3069
(1978).
3. Klapper, D. G., et al., Endocrinology, 112,
2215-7 (1983).
4. Zumstein, P., and Stiles, C. D., J. Biol. Chem.,
262, 11252-60 (1987).
Product Information Sheet -SRP3069
(1978).
3. Klapper, D. G., et al., Endocrinology, 112,
2215-7 (1983).
4. Zumstein, P., and Stiles, C. D., J. Biol. Chem.,
262, 11252-60 (1987).
Data Sheet -NovaSeptum® SURe
Storage) –80 to 125 °C
(–112 to 257 °F)
C-Flex® designs –80 (when used with a
NovaSeptum® Case) to
50 °C (–112 to 122 °F)
–80 to 50 °C
(–112 to
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
35
26 18 25 23 112 54 34 111 21 59 1377 38 39 157 36
std
6
26 16 22 20 104 58 37 112 21 67 5904 38 42 155 35
26 17 24
Flyer Rediscover Thin Layer Chromatography from the world leader
aluminum 1.05553.0001 5553-7
PLC silica
gel 60 F254
20 x 20 0.5 mm 20 plates glass 1.05744.0001 5744-7
20 x 20 1 mm 15 plates glass 1.13895.0001 13895-7
HPTLC silica
gel 60 F254
The Effective Use of Protein Kinase Inhibitors
94 103
69
109 20 105 86 90 3 3 96 89 71 93 76 94 96
7 2 18 22 5 75 68 84 54 20 94 97 73 75
15 6 62 116 102
The Effective Use of Protein Kinase Inhibitors
94 103
69
109 20 105 86 90 3 3 96 89 71 93 76 94 96
7 2 18 22 5 75 68 84 54 20 94 97 73 75
15 6 62 116 102
Product Information Sheet-11426338910
204 521 001
ABTS Buffer, 125 ml 11 204 530 001
ABTS Buffer, 16.7 g for 1 l 11 112 597 001
ABTS Tablets, 50 mg 11 112 422 001
1 2 3
1 2 3
Product Information Sheet-11426346910
204 521 001
ABTS Buffer, 125 ml 11 204 530 001
ABTS Buffer, 16.7 g for 1 l 11 112 597 001
ABTS Tablets, 50 mg 11 112 422 001
1 2 3
1 2 3
Data Sheet - C9774 - Lot 076K8807
requirements Pass
Specific rotation, [α]D25
5 mg/ml solution in alcohol
between +105° and +112° +108°
Assay high pressure
liquid chromatography
not less than 97.0% and not more than
Data Sheet - A5102
2000).
5. Giet, R., and Prigent, C., J. Cell Sci., 112,
3591-3601 (1999).
6. Bolton, M.A., et al., Mol. Biol. Cell, 13, 3064-3077
(2002).
7. Murata-Hori, M., et al., Mol. Biol. Cell, 13,
1099
Data Sheet - C9774 - Lot 079H8805
passes
Specific rotation, [α]D25
5 mg/ml solution in alcohol
〈781S〉
between + 105° and + 112° + 107°
Assay high pressure
liquid chromatography
〈621〉
not
Data Sheet - C9774 - Lot 79H8805
passes
Specific rotation, [α]D25
5 mg/ml solution in alcohol
〈781S〉
between + 105° and + 112° + 107°
Assay high pressure
liquid chromatography
〈621〉
not
Product Information Sheet - C2882
: 516-92-7
Synonym: Epicoprostanol
Product description
Molecular formula:C27H48O
Molecular weight: 388.67
[α]D (C = 1 in chloroform): 29.5-32.5°
Melting point: 108-112 °C
5β-
Product Information Sheet - L5135
stearothermophilus: identification of
active lysine by modification with pyridoxal
phosphate. J. Biochem., 112, 258-265 (1992).
3. Morishita, Y., et al., Kinetic assay of serum and
urine for urea with
Data Sheet - I3769
(1978).
3. Klapper, D. G. et al., Endocrinology, 112, 2215-7
(1983).
4. Zumstein, P., and Stiles, C.D., J. Biol. Chem., 262,
11252-60 (1987).
BG,LCM,KAA,MAM 03/16-1
2016 Sigma-Aldrich
Data Sheet: NovaSeptum® GO Sterile Sampling System
size, do not fill
more
than 400 mL.
2 to 60 °C
(36 to 140 °F)
Single 5 mL:
–80 to 134 °C
(–12 to 273 °F)
Single 20 mL:
–80 to 121 °C
Data Sheet - M4810
0.2 (Kd)
4-DAMP-Methiodide 2.5
p-F-Hexahydro-sila-difenidol 50
Pirenzepine 65
Methoctramine 112
Affinity Constants for selected agonists
Ligand KH
(µM)
KL
(µM)
High
affinity
sites (%)
Product Information Sheet-11383213001
093 657 910
Blocking Reagent 27 g, for one liter blocking solution,
Not available in US
11 112 589 001
Tris hydrochloride 500 g 10 812 846 001
Streptavidin Conjugates Streptavidin-AP Conjugate
Data Sheet - SAB4200247
J. Haematol., 68, 67-74
(1988).
2. Bray, B.F., Trans. Am. Clin. Climatol. Assoc., 117,
103–112 (2006).
3. Du, X., Curr. Opin. Hematol., 14, 262-269 (2007).
4. Luo, S.Z., and Li, R., J. Mol. Biol
Product Information Sheet-11383221001
US 11 112 589 001
Tris hydrochloride 500 g 10 812 846 001
Streptavidin Conjugates Streptavidin-AP Conjugate, 1,000 U 11 089 161 001
Streptavidin-β-Gal Conjugate, 500 U, Not available in US 11 112 481
Data Sheet - H157
receptor antagonist, HOE 140, in
isolated blood vessels from different species. Br. J.
Pharmacol., 112, 683-689 (1994).
Wirth, K., et al., Hoe 140, a new potent and long acting
bradykinin antagonist:
Data Sheet - S4947
eukaryotes. Members of this family contain a 250
amino acid core domain that shares about 25-60%
sequence identity.7 The mammalian Sir2 gene family is
comprised of seven members which are designated
SIRT1
Data Sheet - S5196
Brachmann, C.B. et al., Genes Dev., 9, 2888-2902
(1995).
6. Gali, V. et al., Nature, 403, 108-112 (2000).
7. Moazed, D. et al., Curr. Opin. Cell Biol., 13, 232-
238 (2001).
8. Smith, J.S.
Product Information Sheet - L0881
Narcissus pseudonarcissus 26 2 (h) α-D-man
Perseau americana − − − −
Phaseolus coccineus 112 4 − −
Phaseolus limensis 247(II) 8 A galNAc
Monoclonal Anti-Cathepsin L Clone CPL33/1 (C4618)
References
1. Weber, E., et al., Hybridoma, 16, 159-165 (1997).
2. Tolosa, E., et al., J. Clin. Invest., 112, 517-526
(2003).
3. Turk, B., and Stoka, V., FEBS Lett., 581, 2761-
2767 (2007).
4. Igdoura
Monoclonal Anti-Procathepsin L Clone CPLH-2D4 (C0994)
Weber, E., et al., Hybridoma, 16, 159-165 (1997).
3. Tolosa, E., et al., J. Clin. Invest., 112, 517-526
(2003).
4. Turk, B., and Stoka, V., FEBS Lett., 581, 2761-
2767 (2007).
5.
Page 1 of 11